we lost more than dollars today. over the last week the ibb and bio tech stocks in general were getting hit but srpt generally held and in some cases went up. i call that momentum. today that momentum was shot and killed by the af article. i asked in another post if anyone would like to call the bottom on srpt and when. will it be tomorrow and how low --- 33 32.50 32 where?
there is one difference between af and us. some short talks to him and he post his opinion and the world sees it and reacts to it. the rest of us have to sit here and suck on it as the price drops. it happens all the time on bios that i am in with a big short postion. as soon as it starts to get some upward momentum the short whispers in af's ear and out comes an af article and the momentum is killed and the price drops. that is the difference in being on a yahoo mb and having af present your case. it sucks.the only question is how far down and for how long will it go.
why was it that awhile back af liked srpt and now he talks to his buddy and doesn't. sounds like some short buddies of his need some help. keep in mind there where a lot of bio's that he didn't like and got approved sometimes costing investors big bucks. i was in dendreon before the adcom panel. he said get out a lot did but i didn't. the price was 2.75 the day before the next ,monring after the adcom voted 14 to 1 the stock opened at 22+. imagine if you had listened to him. what he failed to say was that the nda was approved that the testing is going well the adcom will be the tell and the accelrated approval was granted --- all good signs. this will be approved in spite of him but he certainly cut the positive momentum of the stock over the last week or so.
it trades at these levels because of: the carppy market , a lack of info, shorts and their IB buddies, puts and calls, and the etf world -- the bio's generally follow the etfs like ibb and the short etf, when the etf' and mutual fund balance their fund they buy and sell without regard to fundementals
versus bmrn. however i will continue to post asking all of you why you continue to respond to the short neo who says he is long and for that matter pearsy. they post non stop negative post abour srpt 7 days a week. it would be one think if they engaged in different topics but it is the same bs post.new just posted again and it has to be the 10th time at least he brings up the number of boys. srpt longs stop enganging him and perasyb (same nut baill)
who are you trying to convince -- the nay sayers neo and pearsby. i have decided not to waste anymore time replying to anyone. srpt is a done deal. i'll sit and wait for feb 26 16 for the approval. the naysayers keep posting the same drivel over and over. i am not waisting anymore time. adios.
i thoght comments like berg would stop given the addtional data coming in october, the fda nda approval and more importantly the accelerated approval. in the fda world this is as close to a lock bet as i have seen it.
ask yourself this -- was that the true bottom for the market. my experience is that it goes down then recovers and then back down. it is called lower highs and lower lows on the way to the true bottom that no one can predict. so cldx will go where the market goes, at least until the middle of 2016.
i have suggested this to all of you. sell your cldx and buy srpt. srpt has three major events between now and next feb 26 -- new data release in oct, an adcom in november and the fda padufa in feb16. it will be over 100 after the approva in feb16l. then come back to cldx in march or april 16 to the run up here. the price of cldx won't move much until then. that is my plan but i already sold my cldx awhile back and bought srpt.
Oh weelllll - i will try to show you -- i did not say there is a one to one correspondence on the calls to the shorts. There are and i say it again professional shorts that use calls as insurance. There are also professional short that naked short -- no calls -- don't bother telling me it is illegal. If you just look at the january 2016 call list you will find calls that would cover about 2.5 million shares. If you want to do some work and guys like you never do -- you just say i am wrong go add all the calls out to the end of time i'd bet that it would cover 75 to 80% of the short.
As i have said in another post they are going to get about 500 million in cash and if they gave srpt 4.1 billion, 100 per share, they could give us the 500 million and about 35 million shares of bmrn and that would make it 4.1 billion -- 35 million newly issued shares is not that big a deal for a company like bmrn -- but as someone immeditately pointed out to me is ---"that will never happen" -- with a lot of substance to bake it up.
i don't believe in short squeezes. the professional shorts will short a stock down to a target and then buy calls to offset the risk. that is why there are still a log of shorts but there are also a lot of calls.
neo is pro bmrn he is always spreading fud.he says he also likes srpt but there is always a backhand slap to the face of srpt every time he post. i stop engaging him and the every lovng pearsby (sic). it gets nowhere. both of them keep posting the same bs over and over.
My understanding is that formal communcations are faxed. My understanding is that it is in the afternoon after they call the parties and tell them the fax is on the way. When the management releases it is up to the manangement within the legal guidelines of material information. I hope they do it at 925 tomorrow moring to prevent the #$%$ shorts from manipulating the price down in the pre market. Finally, the fda has until tomorrow the 26th --- i think.